Sickle cell gene therapy shows promise in reducing pain crises

NCT ID NCT05353647

First seen May 12, 2026 · Last updated May 12, 2026

Summary

This study tests a gene therapy that modifies a patient's own blood stem cells to increase fetal hemoglobin, a healthy type that prevents sickling. The goal is to reduce or eliminate severe pain crises in people with sickle cell disease. The trial involves 25 participants aged 13 to 40 with severe disease, and uses a virus to deliver the genetic change. While the approach aims for long-term benefit, patients may still require ongoing care, so it is classified as disease control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

  • Children's Healthcare of Atlanta/Emory University

    Atlanta, Georgia, 30322, United States

  • Children's Hospital of Los Angeles

    Los Angeles, California, 90027, United States

  • Dana-Farber Cancer Institute/Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • UC Davis Medical Center

    Sacramento, California, 95817, United States

  • UCLA Medical Center

    Los Angeles, California, 90095, United States

  • UCSF Benioff Children's Hospital Oakland

    Oakland, California, 94609, United States

Conditions

Explore the condition pages connected to this study.